BRPI0516542A - composição de vacina eficaz na prevenção ou melhora de infecção pelo vìrus da influenza aviária; método para prevenir ou melhorar a eclosão de infecção pelo vìrus da influenza aviária - Google Patents

composição de vacina eficaz na prevenção ou melhora de infecção pelo vìrus da influenza aviária; método para prevenir ou melhorar a eclosão de infecção pelo vìrus da influenza aviária

Info

Publication number
BRPI0516542A
BRPI0516542A BRPI0516542-3A BRPI0516542A BRPI0516542A BR PI0516542 A BRPI0516542 A BR PI0516542A BR PI0516542 A BRPI0516542 A BR PI0516542A BR PI0516542 A BRPI0516542 A BR PI0516542A
Authority
BR
Brazil
Prior art keywords
influenza virus
avian influenza
infection
preventing
composition
Prior art date
Application number
BRPI0516542-3A
Other languages
English (en)
Inventor
Juan Plana-Duran
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0516542A publication Critical patent/BRPI0516542A/pt
Publication of BRPI0516542B1 publication Critical patent/BRPI0516542B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOSIçãO DE VACINA EFICAZ NA PREVENçãO OU MELHORA DE INFECçãO PELO VìRUS DA INFLUENZA AVIáRIA; MéTODO PARA PREVENIR OU MELHORAR A ECLOSãO DE INFECçãO PELO VìRUS DA INFLUENZA AVIáRIA. A invenção refere-se a uma composição de vacina que é eficaz na prevenção ou melhora de infecção pelo vírus da influenza aviária. A vacina contém pelo menos duas cepas inativadas do vírus da influenza aviária, onde o total de hemaglutinina (HA) combinada é de pelo menos cerca de 256 HA/dose da composição da vacina, e onde cada uma das cepas apresenta pelo menos cerca de 128 NA/dose, e onde ainda uma das cepas tem o mesmo subtipo NA que um vírus provocador, e onde pelo menos uma das cepas tem um subtipo NA diferente do vírus provocador.
BRPI0516542A 2004-10-07 2005-10-06 composição de vacina bivalente eficaz na prevenção ou melhora de infecção pelo vírus da influenza aviária BRPI0516542B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61670704P 2004-10-07 2004-10-07
US64845905P 2005-01-31 2005-01-31
PCT/US2005/035925 WO2006041978A2 (en) 2004-10-07 2005-10-06 Multivalent avian influenza vaccines

Publications (2)

Publication Number Publication Date
BRPI0516542A true BRPI0516542A (pt) 2008-09-09
BRPI0516542B1 BRPI0516542B1 (pt) 2015-11-17

Family

ID=36148890

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516542A BRPI0516542B1 (pt) 2004-10-07 2005-10-06 composição de vacina bivalente eficaz na prevenção ou melhora de infecção pelo vírus da influenza aviária

Country Status (17)

Country Link
US (1) US8067013B2 (pt)
EP (1) EP1796720B1 (pt)
JP (1) JP5105524B2 (pt)
KR (1) KR101370464B1 (pt)
CN (1) CN101035559B (pt)
AP (1) AP2167A (pt)
AR (1) AR051636A1 (pt)
AU (1) AU2005294322A1 (pt)
BR (1) BRPI0516542B1 (pt)
CA (1) CA2581355C (pt)
ES (1) ES2467094T3 (pt)
MX (1) MX2007004004A (pt)
MY (1) MY153290A (pt)
NZ (1) NZ553975A (pt)
TW (1) TWI365074B (pt)
WO (1) WO2006041978A2 (pt)
ZA (1) ZA200702876B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007053899A1 (en) * 2005-11-10 2007-05-18 Diva Solutions Pty Ltd Differentiating therapeutic composition
US9072701B2 (en) 2006-04-21 2015-07-07 St. Jude Children's Research Hospital Avian influenza viruses, vaccines, compositions, formulations, and methods
US20100098721A1 (en) * 2006-10-18 2010-04-22 St. Jude Children's Reseach Hospital Methods and compositions for preparing a universal influenza vaccine
CL2008000747A1 (es) * 2007-03-16 2008-04-25 Wyeth Corp Composicion de vacuna que comprende una primera y una segunda cepa inactivada del virus de la influenza aviar; metodo para vacunar un ave.
GB0810305D0 (en) * 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
US9421251B2 (en) 2008-06-25 2016-08-23 Novartis Ag Rapid responses to delayed booster immunisations
TWI444195B (zh) 2008-10-08 2014-07-11 Pokka Corp Anti-avian influenza virus agents and products containing anti-avian influenza virus agents
WO2016192670A1 (en) * 2015-06-04 2016-12-08 The University Of Hong Kong Live-attenuated virus and methods of production and use
KR101964044B1 (ko) 2018-03-14 2019-04-02 인제대학교 산학협력단 재조합 아데노바이러스를 이용한 다가형 인플루엔자 생백신 플랫폼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US6159472A (en) * 1998-11-16 2000-12-12 Akzo Nobel N.V. Intradermal Avian immunization with inactivated vaccines
WO2003086453A1 (en) 2002-04-12 2003-10-23 Ilaria Capua Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

Also Published As

Publication number Publication date
ES2467094T3 (es) 2014-06-11
ZA200702876B (en) 2008-09-25
BRPI0516542B1 (pt) 2015-11-17
US20060204976A1 (en) 2006-09-14
CN101035559B (zh) 2011-08-17
CA2581355A1 (en) 2006-04-20
WO2006041978A2 (en) 2006-04-20
WO2006041978A3 (en) 2006-08-03
CN101035559A (zh) 2007-09-12
TW200617166A (en) 2006-06-01
AP2167A (en) 2010-11-12
EP1796720B1 (en) 2014-04-23
AU2005294322A1 (en) 2006-04-20
EP1796720A2 (en) 2007-06-20
TWI365074B (en) 2012-06-01
AR051636A1 (es) 2007-01-31
MX2007004004A (es) 2007-05-10
KR20070059180A (ko) 2007-06-11
KR101370464B1 (ko) 2014-03-06
US8067013B2 (en) 2011-11-29
JP2008515906A (ja) 2008-05-15
AP2007003955A0 (en) 2007-07-30
NZ553975A (en) 2010-04-30
MY153290A (en) 2015-01-29
JP5105524B2 (ja) 2012-12-26
CA2581355C (en) 2016-01-26

Similar Documents

Publication Publication Date Title
BRPI0516542A (pt) composição de vacina eficaz na prevenção ou melhora de infecção pelo vìrus da influenza aviária; método para prevenir ou melhorar a eclosão de infecção pelo vìrus da influenza aviária
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
BR112023000323A2 (pt) Vacina combinada contra sars-cov-2 e influenza
BR112012004806B8 (pt) composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso
BR112016005270A2 (pt) compostos de aza-piridona, composições farmacêuticas e seus usos
BR112015022514A2 (pt) composições que compreendem selênio e uso das mesmas para o tratamento e prevenção de doença ou condições associadas à disfunção mitocondrial
BR112015023922A2 (pt) composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes
BRPI0814899A2 (pt) Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"
PE20140646A1 (es) Vacuna de virus de dengue inactivado
EP2078083A4 (en) NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR
BR112017000519A2 (pt) "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica"
BRPI1009842B8 (pt) uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
MY201105A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
EA201791903A1 (ru) β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ
BR112015018693A2 (pt) composições compreendendo um agente de controle biológico à base de streptomyces e um inseticida
BR112018068342A2 (pt) vacina de vírus zika vivo atenuado
BR112022017923A2 (pt) Tratamento de infecção por coronavírus
BR112021019845A2 (pt) Composições de vírus inativado e formulações de vacina contra zika
CO2020004801A2 (es) Uso de suplementos de aminoácidos para mejorar la síntesis de proteínas musculares
BR112019006802A2 (pt) compostos e métodos para diagnóstico e tratamento de infecções virais
BR112014010587A2 (pt) biocontrole de nematódeos
BR112017023448A2 (pt) composições anti-fitopatogênicas
BR112014003278A2 (pt) vacinas para influenza h5
BR112022018504A2 (pt) Usos de uma composição

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved